Sparsentan (SPAR) as First-Line Treatment of Incident Patients with IgA Nephropathy: Interim Analysis of the SPARTAN Trial

Authors: Chee Kay Cheung, Stephanie Moody, Neeraj Dhaun, Sian V. Griffin, Alexandra Louise Howson, Radko Komers, Alex Mercer, Matthew Sayer, Smeeta Sinha, Lisa C. Willcocks, Jonathan Barratt

Published: 2024-10-28

DOI: 10.1681/asn.20240s2q2237

Keywords: No keywords found.

Abstract:
No abstract found.

Source: